King Hussein Cancer Center

From Wikipedia, the free encyclopedia
Jump to: navigation, search
King Hussein Cancer Center (مركز الملك حسين للسرطان)
King Hussein Cancer Center
KingHusseinCancerCenterlogo.png
Geography
Location Queen Rania Street, Amman,  Jordan
Organisation
Care system Comprehensive Cancer Care
Hospital type Cancer Care
Affiliated university

. Agreements and partnerships:

  • St. Jude Children’s Research Hospital, USA
  • The University of Texas M.D. Anderson Cancer Center, USA
  • Lombardi Cancer Center of Georgetown University, USA
  • Moffitt Cancer Center, USA
  • The National Cancer Institute, Egypt
  • The Hospital for Sick Children, Canada
  • The Stefan Morsch Foundation, Germany
  • Susan G. Komen for the Cure, USA
  • Roswell Park Cancer Institute, New York, USA
  • University of Jordan, Amman, Jordan
Services
Beds 180
History
Founded 1997
Links
Website http://www.khcc.jo/ King Hussein Cancer Center
King Hussein Cancer Center under expansion.

The King Hussein Cancer Center (KHCC) (Arabic مركز الملك حسين للسرطان),[1] is a medical center in Amman, Jordan. It treats both adult and pediatric patients. KHCC treats over 3500 new cancer patients every year from Jordan and the region.

KHCC has established programs that focus on all stages of comprehensive cancer care: from prevention and early detection, through diagnosis and treatment, to palliative care. The King Hussein Cancer Foundation (KHCF), founded in 1997, undertakes various fundraising activities to support and maintain the mission of KHCC as a comprehensive cancer center of excellence. KHCF is a free-standing, independent, non-governmental, nonprofit organization established by a royal decree to combat cancer in Jordan and the Middle East region. The foundation and center is run by a board of trustees consisting of a dedicated group of prominent volunteers and chaired by HRH Princess Ghida Talal. The director general of KHCF is HRH Princess Dina Mired and Dr. Asem Mansour is the director general of KHCC.[2]

Princess Ghida serves as the Chair of the Board of Trustees of the King Hussein Cancer Foundation.

History[edit]

Prior to the mid-1980s, there was no infrastructure for treating cancer patients in Jordan. For quality care, wealthy patients sought treatment abroad, while those without means were treated locally, with limited resources and poor results.

In 1997, the Al-Amal Center, meaning "The Center of Hope", opened its doors. This much-needed cancer-specific hospital was established to provide the many patients in Jordan with quality care comparable to that offered in the West. To honor the late King Hussein, who had died of cancer, the center was renamed the King Hussein Cancer Center in 2002.

From 2002-2006, the hospital intensely focused on areas of quality control, and the recruitment of highly qualified staff. Patients, patient services, programs and staff exponentially increased at a rapid pace. The focus, from its inception, was to deliver the highest level of care in a safe environment.

In 2006, Mahmoud Sarhan became the director general and CEO of the King Hussein Cancer Center. Dr. Sarhan, a former professor of pediatrics in the Bone Marrow and Stem Cell Transplantation Program at Duke University, was an instrumental figure in the center’s establishment. He founded KHCC's bone marrow transplantation (BMT) program in 2003, a program which has become one of the largest and most successful BMT programs in the Middle East. It is one of the largest (performing approximately 100 bone marrow transplants each year) and most successful programs in the Middle East, achieving cure rates compatible with international standards. The program oversees both matched allogeneic and autologous transplants and performs transplants utilizing cord blood, making it the only program in Jordan and the second in the region that offers such a highly specialized procedure. Other non-cancer cases are also treated through the KHCC BMT program including thalassemia, aplastic anemia and other metabolic diseases.

Accreditations[edit]

  • Joint Commission International Accreditation (JCI), (February 2006).
  • JCI Disease Specific Certification (DSC) - First cancer center outside of the United States, (November 2007).[3]
  • Hazard analysis and critical control points (HACCP) Systems and Guidelines for its Application, (April 2008).
  • College of American Pathologists Accreditation (CAP), (July 2009).
  • Health Care Accreditation Council of Jordan, (August 2009).

International affiliations[edit]

Activities[edit]

In 2007, KHCF and KHCC were entrusted to lead the first national breast cancer program, Jordan Breast Cancer Program (JBCP), in partnership with the Ministry of Health and other stakeholders. The main objectives of the program are to reduce morbidity and mortality from breast cancer through awareness campaigns, early detection and access to screening for all women in Jordan in order to shift the current state of diagnosis to the early stages of the disease, when it is most curable with high survival rates.

JBCP’s operations are managed by an executive board led by KHCC and KHCF which provides its direction and ensures the implementation of action plans. HRH Princess Dina Mired, director general of KHCF and Dr. Mahmoud Sarhan, director general of KHCC, together chair the Jordan Breast Cancer Committee and the executive board.

In 2010, the King Hussein Cancer Center and the American University of Beirut Medical Center signed a memorandum of understanding to create a joint program in research.[5]

See also[edit]

King Hussein Medical Center Amman

References[edit]

External links[edit]

Coordinates: 32°00′16″N 35°52′30″E / 32.0045°N 35.8750°E / 32.0045; 35.8750